Haematological malignancies

Gene: PAX5

Green List (high evidence)

PAX5 (paired box 5, Ensemblv90)
EnsemblGeneIds (GRCh38): ENSG00000196092
EnsemblGeneIds (GRCh37): ENSG00000196092
OMIM: 167414, ClinGen, DECIPHER
PAX5 is in 1 panel

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

5 unrelated families reported, p.Gly183Ser is recurrent, reported in 3/5.
Created: 2 Nov 2020, 1:50 p.m. | Last Modified: 2 Nov 2020, 1:50 p.m.
Panel Version: 0.90

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
{Leukemia, acute lymphoblastic, susceptibility to, 3}, MIM# 615545

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Green
  • Curated sources
  • Victorian Clinical Genetics Services
Phenotypes
  • No other known cancer risks
  • ALL, B-ALL
  • Class: familial predisp to leukaemia (typ AD)
  • PAX5-related familial ALL, Susceptibility to ALL 3
OMIM
167414
ClinGen
PAX5
DECIPHER
PAX5
Clinvar variants
Variants in PAX5
Penetrance
None
Publications
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
7 Feb 2026, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: pax5 has been classified as Green List (High Evidence).

7 Feb 2026, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: PAX5 was added gene: PAX5 was added to Haematological malignancies cancer susceptibility. Sources: Curated sources,Expert Review Green Mode of inheritance for gene: PAX5 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Publications for gene: PAX5 were set to 27881370; 28297620 Phenotypes for gene: PAX5 were set to No other known cancer risks; ALL, B-ALL; Class: familial predisp to leukaemia (typ AD); PAX5-related familial ALL, Susceptibility to ALL 3